Works by Makumbi, Shafic

Results: 3
    1

    Influence of age and co‐medication on dolutegravir glucuronidation in paediatric patients.

    Published in:
    British Journal of Clinical Pharmacology, 2024, v. 90, n. 11, p. 2947, doi. 10.1111/bcp.16238
    By:
    • Jacobs, Tom G.;
    • Waalewijn, Hylke;
    • Houlden, Lily;
    • Bollen, Pauline D. J.;
    • Nanduudu, Annet;
    • Nambi, Esether;
    • Cassim, Haseena;
    • Lugemwa, Abbas;
    • Makumbi, Shafic;
    • Monkiewicz, Lara N.;
    • Shakeshaft, Clare;
    • Bamford, Alasdair;
    • Archary, Moherndran;
    • Musuro, Godfrey;
    • Chidziva, Ennie;
    • Mujuru, Hilda A.;
    • Bwakura‐Dangarembizi, Mutsa;
    • Chabala, Chishala;
    • Turkova, Anna;
    • Gibb, Di M.
    Publication type:
    Article
    2
    3

    First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial.

    Published in:
    Clinical Infectious Diseases, 2023, v. 77, n. 6, p. 875, doi. 10.1093/cid/ciad267
    By:
    • Waalewijn, Hylke;
    • Szubert, Alexander J;
    • Wasmann, Roeland E;
    • Wiesner, Lubbe;
    • Chabala, Chishala;
    • Bwakura-Dangarembizi, Mutsa;
    • Makumbi, Shafic;
    • Nangiya, Joan;
    • Mumbiro, Vivian;
    • Mulenga, Veronica;
    • Musiime, Victor;
    • Monkiewicz, Lara N;
    • Griffiths, Anna L;
    • Bamford, Alasdair;
    • Doerholt, Katja;
    • Denti, Paolo;
    • Burger, David M;
    • Gibb, Diana M;
    • McIlleron, Helen M;
    • Colbers, Angela
    Publication type:
    Article